Skip to content

Added to your cart:

Cart subtotal

Rho (D) Immune Globulin (Human) HyperRHO S/D Mini-Dose 250 IU (50 MCG) Prefilled Syringes 10/Box (Rx)

SKU 13533-0661-06
Sale 35%
Original price $ 689.95
Current price $ 449.00
Non-Returnable
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Save 35% ($ 240.95)
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Sale 35%
Original price $ 689.95
Current price $ 449.00
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Rho (D) Immune Globulin (Human) HyperRHO S/D Mini-Dose 250 IU (50 MCG) Prefilled Syringes 10/Box (Rx)
Rho (D) Immune Globulin (Human) HyperRHO S/D Mini-Dose 250 IU (50 MCG) Prefilled Syringes 10/Box (Rx)
$ 689.95 $ 449.00
🔒 Medical License Required
Description
HyperRHO® S/D Mini-Dose (RhO[D] immune globulin [human]) is recommended to prevent the isoimmunization of RhO(D)-negative women at the time of spontaneous or induced abortion of up to 12 weeks' gestation provided the following criteria are met: The mother must be RhO(D) negative and must not already be sensitized to the RhO(D) antigen. The father is not known to be RhO(D) negative. Gestation is not more than 12 weeks at termination.

HyperRHO S/D is an immune globulin with a high level of preformed antibodies against rhesus (Rh)-positive blood cells.
The injection of an RHO(D) immune globulin provides a passive immunity for rapid immune protection and an acute response in high-risk situations.
HyperRHO S/D destroys any Rh-positive blood cells that may have entered the mother's bloodstream and prevents the mother's immune system from producing Rh-positive antibodies, thus protecting the baby from developing hemolytic disease.

Each single-dose syringe of HyperRHO S/D contains sufficient anti-RhO(D) to effectively suppress the immunizing potential of 15 mL of Rh-positive red blood cells.

Antepartum and postpartum administration of a single dose of HyperRHO S/D to susceptible Rh-negative women reduces the incidence of Rh isoimmunization to less than 0.1%.

Effective Protection
HyperRHO S/D destroys Rh-positive cells in the mother's body, prevents the mother's immune system from producing Rh-positive antibodies, and protects the baby from contracting HDN.

Get Notified When Back in Stock